BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29523219)

  • 1. TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis.
    Shen X; Gao X; Li H; Gu Y; Wang J
    Oncol Res; 2018 Dec; 27(1):73-80. PubMed ID: 29523219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of S100A4 chemosensitizes human laryngeal carcinoma cells in vitro through inhibition of Slug.
    Liang DP; Huang TQ; Li SJ; Chen ZJ
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3484-90. PubMed ID: 25491625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells.
    Zhu C; Pan Y; He B; Wang B; Xu Y; Qu L; Bao Q; Tian F; Wang S
    Oncol Rep; 2011 Feb; 25(2):425-32. PubMed ID: 21165561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.
    Liu J; Tang Q; Li S; Yang X
    Oncotarget; 2016 Dec; 7(52):86446-86456. PubMed ID: 27880721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
    Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
    Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance.
    Yuan Z; Xiu C; Song K; Pei R; Miao S; Mao X; Sun J; Jia S
    J Cell Mol Med; 2018 Sep; 22(9):4253-4262. PubMed ID: 29971915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells.
    Zhang F; Yang B; Shi S; Jiang X
    Acta Histochem; 2014 Jul; 116(6):1000-6. PubMed ID: 24831064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
    Liu T; Peng H; Zhang M; Deng Y; Wu Z
    Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.
    Xu YY; Wu TT; Zhou SH; Bao YY; Wang QY; Fan J; Huang YP
    Int J Clin Exp Pathol; 2014; 7(7):3938-47. PubMed ID: 25120770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beclin1 enhances cisplatin-induced apoptosis via Bcl-2-modulated autophagy in laryngeal carcinoma cells Hep-2.
    Yang M; Yang XM; Yin DH; Tang QL; Wang L; Huang C; Li P; Li SS
    Neoplasma; 2018; 65(1):42-48. PubMed ID: 29322787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heme oxygenase-1 enhances the chemosensitivity of laryngeal squamous cell cancer Hep-2 cells to cisplatin.
    Lv X; Song DM; Niu YH; Wang BS
    Apoptosis; 2016 Apr; 21(4):489-501. PubMed ID: 26801320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-
    Chen J; Zhang L; Shu Y; Chen L; Zhu M; Yao S; Wang J; Wu J; Liang G; Wu H; Li W
    Biomed Res Int; 2017; 2017():4751260. PubMed ID: 28409156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
    Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
    J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of c-Met inhibitor AMG-102 on radiosensitivity in laryngeal squamous carcinoma cells].
    Cao F; Lyu X; Dong KF; Fan C; Zhang JJ; Chen K; Ma BJ; Hou CL; Zhang CH
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):909-917. PubMed ID: 31874548
    [No Abstract]   [Full Text] [Related]  

  • 15. The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
    Shao F; Lv M; Zheng Y; Jiang J; Wang Y; Lv L; Wang J
    Biochimie; 2015 Dec; 119():183-91. PubMed ID: 26549486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.
    Xiang C; Lv Y; Wei Y; Wei J; Miao S; Mao X; Gu X; Song K; Jia S
    Cell Physiol Biochem; 2015; 36(2):435-45. PubMed ID: 25968442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion.
    Si L; Zheng L; Xu L; Yin L; Han X; Qi Y; Xu Y; Wang C; Peng J
    Eur J Pharmacol; 2016 Mar; 774():105-17. PubMed ID: 26849940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of siRNA interference after laryngeal cancer Hep-2 cells to cisplatin sensitivity of β-catenin gene expression].
    Yu F; Huang X; Ai M; Lin Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jul; 29(13):1143-7. PubMed ID: 26540910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
    Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
    Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.